320 related articles for article (PubMed ID: 37841420)
1. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
[TBL] [Abstract][Full Text] [Related]
2. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
3. Radiomics nomogram for prediction of microvascular invasion in hepatocellular carcinoma based on MR imaging with Gd-EOB-DTPA.
Zhang S; Duan C; Zhou X; Liu F; Wang X; Shao Q; Gao Y; Duan F; Zhao R; Wang G
Front Oncol; 2022; 12():1034519. PubMed ID: 36387156
[TBL] [Abstract][Full Text] [Related]
4. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
5. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence.
Chong H; Gong Y; Zhang Y; Dai Y; Sheng R; Zeng M
Acad Radiol; 2023 Jan; 30(1):49-63. PubMed ID: 35562264
[TBL] [Abstract][Full Text] [Related]
6. Delta-radiomics models based on multi-phase contrast-enhanced magnetic resonance imaging can preoperatively predict glypican-3-positive hepatocellular carcinoma.
Han Z; Dai H; Chen X; Gao L; Chen X; Yan C; Ye R; Li Y
Front Physiol; 2023; 14():1138239. PubMed ID: 37601639
[No Abstract] [Full Text] [Related]
7. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study.
Tian Y; Hua H; Peng Q; Zhang Z; Wang X; Han J; Ma W; Chen J
J Magn Reson Imaging; 2022 Nov; 56(5):1459-1472. PubMed ID: 35298849
[TBL] [Abstract][Full Text] [Related]
8. Radiomic Analysis of Contrast-Enhanced CT Predicts Glypican 3-Positive Hepatocellular Carcinoma.
Sun S; Xiao S; Jiang Z; Xiao J; He Q; Wang M; Fan Y
Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38462828
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
[TBL] [Abstract][Full Text] [Related]
10. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
[TBL] [Abstract][Full Text] [Related]
12. [The application value of Gd-EOB-DTPA enhanced MRI based radiomics in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia in hepatobiliary phase].
Mao HY; Yu YX; Zhang JY; Zhang T; Fan YF; Hu S; Wang XM; Hu CH
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(33):2599-2606. PubMed ID: 37650206
[No Abstract] [Full Text] [Related]
13. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma.
Mao Y; Wang J; Zhu Y; Chen J; Mao L; Kong W; Qiu Y; Wu X; Guan Y; He J
Hepatobiliary Surg Nutr; 2022 Feb; 11(1):13-24. PubMed ID: 35284527
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
Zhang Z; Jiang H; Chen J; Wei Y; Cao L; Ye Z; Li X; Ma L; Song B
Cancer Imaging; 2019 May; 19(1):22. PubMed ID: 31088553
[TBL] [Abstract][Full Text] [Related]
15. A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Yang L; Gu D; Wei J; Yang C; Rao S; Wang W; Chen C; Ding Y; Tian J; Zeng M
Liver Cancer; 2019 Oct; 8(5):373-386. PubMed ID: 31768346
[TBL] [Abstract][Full Text] [Related]
16. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
17. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
18. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
19. A Multiparametric MRI-Based Radiomics Nomogram for Preoperative Prediction of Survival Stratification in Glioblastoma Patients With Standard Treatment.
Jia X; Zhai Y; Song D; Wang Y; Wei S; Yang F; Wei X
Front Oncol; 2022; 12():758622. PubMed ID: 35251957
[TBL] [Abstract][Full Text] [Related]
20. MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer.
Li H; Chen XL; Liu H; Lu T; Li ZL
Front Oncol; 2022; 12():1087882. PubMed ID: 36686763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
